Effect of estrogen receptors (reports from the FDA, NIH, ACOG, and NAMS) and the role of testosterone and bone density.
Davis
Daniel
D
US Food and Drug Administration, DHHS, USA.
MacKay
Trent
T
Utian
Wulf
W
Grinspoon
Steven
S
D015519:Bone Density / Q000187:drug effects; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000378:metabolism*; D006331:Heart Diseases / Q000517:prevention & control; D006801:Humans; D009316:National Institutes of Health (U.S.); D010024:Osteoporosis / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011960:Receptors, Estrogen / Q000378:metabolism*; D012955:Societies, Medical; D013739:Testosterone / Q000378:metabolism*; D014481:United States; D014486:United States Food and Drug Administration
D011960:Receptors, Estrogen; D013739:Testosterone